Affordable Access

Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen.

Authors
  • Kennecke, H F
  • Olivotto, I A
  • Speers, C
  • Norris, B
  • Chia, S K
  • Bryce, C
  • Gelmon, K A
Type
Published Article
Journal
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Publication Date
Jan 01, 2007
Volume
18
Issue
1
Pages
45–51
Identifiers
PMID: 17030545
Source
Medline
License
Unknown

Abstract

T and N stages predicted late relapse and death from breast cancer in a population-based cohort of postmenopausal women. Risk estimates reported herein may be used to optimize decision making regarding adjuvant therapy after 5 years of tamoxifen.

Report this publication

Statistics

Seen <100 times